Does the Introduction of Biosimilars Change Our Understanding about Treatment Modalities for Inflammatory Bowel Disease?

Publisher： Karger

E-ISSN： 1421-9875|35|1-2|74-82

ISSN： 0257-2753

Source： Digestive Diseases, Vol.35, Iss.1-2, 2017-02, pp. : 74-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Our Food (Environment) Change Our Gut Microbiome (‘In-Vironment’): A Potential Role for Inflammatory Bowel Disease?

By  

Digestive Diseases, Vol. 30, Iss. 3, 2013-01 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Medical treatment: does it influence the natural course of inflammatory bowel disease?

By Moum B.  

European Journal of Internal Medicine, Vol. 11, Iss. 4, 2000-08 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite

The surgical treatment of inflammatory bowel disease-associated dysplasia

By Connelly Tara M   Koltun Walter A  

Expert Review of Gastroenterology and Hepatology, Vol. 7, Iss. 4, 2013-05 ,pp. : 307-322

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Bowel Disease Characteristics and Treatment in Hispanics and Caucasians

By Hou Jason   El-Serag Hashem   Sellin Joseph   Thirumurthi Selvi  

Digestive Diseases and Sciences, Vol. 56, Iss. 5, 2011-05 ,pp. : 1476-1481

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of anaemia in inflammatory bowel disease with iron sucrose

By Bodemar G.   Kechagias S.   Almer S.   Danielson B. G.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 5, 2004-05 ,pp. : 454-458

Informa Healthcare

Access to resources Recommend Favorite